Mohamed Izham Mohamed Ibrahim,
Albert Wertheimer,
Zaheer-Ud-Din Babar
Elsevier Science
e druk, 2017
9780128112281
Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries
Present Challenges and Future Solutions
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
2017
ISBN13: 9780128112281
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions examines the particularities of low- and middle-income countries and offers solutions based on their needs, culture and available resources. Drawing from the firsthand experience of researchers and practitioners working in these countries, this book addresses the socio-behavioral aspects of pharmacy and health, pharmacoeconomics, pharmaceutical policy, supply management and marketing, pharmacoepidemiology and public health pharmacy specific to low- and middle-income countries.
While some practices may be applied appropriately in disparate places, too often pharmacy practice in low- and middle-income countries is directly copied from successes in developed countries, despite the unique needs and challenges low- and middle-income countries face.
Specificaties
Inhoudsopgave
<p>1. Introduction: Discovering Issues and Challenges in Low- and Middle-Income Countries<br><br>Section I: Socio-behavioral Aspects of Medicines Used in Low- and Middle-Income Countries<br>2. Socio-Behavioral Aspects of Medicine Used in Low- and Middle-Income Countries<br>3. Patients’, Consumers’ and Healthcare Professionals’ Perceptions, Beliefs, Knowledge, Attitudes and Practices Towards the Use of Medicines<br>4. The Use of Measurements and Health Behavioral Models to Improve Medication Adherence</p> <p>Section II: Pharmaceutical Promotion in Low- and Middle-Income Countries<br>5. Academic Detailing in Low- and Middle-Income Countries: Principles, Use, Impact and Lessons Learned<br><br>Section III: Economic Evaluation and Medicine Expenditure in Low- and Middle-Income Countries<br>6. Economic Evaluation and Medicine Expenditure in Low- and Middle-Income Countries<br>7. Medicine Pricing Policy and Strategies in Low- and Middle-Income Countries: A Review <br>8. Economic Evaluation of Predominant Disease in Low- and Middle-Income Countries: Diabetes Mellitus<br><br>Section IV: Pharmacovigilance and Patient Safety in Low- and Middle-Income Countries<br>9. Pharmacovigilance Practices and Activities: Issues, Challenges, and Future Direction<br>10. Behavioral Aspects of Pharmacovigilance: Research Methods Considerations<br>11. Knowledge, Attitude, and Practice of Pharmacovigilance in Low- and Middle-Income Countries<br><br>Section V: Generic Medicines Used in Low- and Middle-Income Countries<br>12. Overcoming Challenges of Generic Medicine Utilization in Low- and Middle-Income Countries: Lessons Learned from International Experiences<br>13. Assessment of Policies, Determinants and Characteristics of Generic Medicine Entry into the Pharmaceutical Markets<br><br>Section VI: Rational and Responsible Medicine Use in Low- and Middle-Income Countries<br>14. Misconceptions and Misues of Drugs by Prescribers, Dispensers and Consumers<br>15. Strengths and Weaknesses of Pharmaceutical Policy in Relation to Rational and Responsible Medicines Use<br>16. Rational and Responsible Medicines Use<br><br>Section VII: Quality of Public Health Pharmacy Services in Low- and Middle-Income Countries<br>17. Quality of Pharmacy Health Services<br>18. Assessment of Medicine Dispensing and Extended Community Pharmacy Services<br>19. Enhancing Quality of Patient-Centered Care Services in Low- and Middle-Income Countries: Pharmaceutical Care Approach<br>20. Politics and Competition between Professions: Future Scope of Pharmacy Practice<br><br>Section VIII: Medicine Quality: Substandard and Counterfeit Medicine in Low- and Middle-Income Countries<br>21. Perspective, Knowledge, Attitude, and Belief of Various Stakeholders on Medicines Quality: Counterfeit and Substandard Medicines<br><br>Section IX: Medicine Information and Health Literacy in Low- and Middle-Income Countries<br>22. Issues on Source, Access, Extent and Quality of Information Available Among Pharmacists and Pharmacy Personnel to Practice Effectively<br><br>Section X: Good Governance and Pharmaceutical Policy in Low- and Middle-Income Countries<br>23. Problems and Obstacles of Low- and Middle-Income Countries in Having Good Governance and Quality and Effective Pharmaceutical Policy<br>24. Pharmacogovernance: Advancing Pharmacovigilance and Patient Safety<br>25. Pharmaceutical Policy: Synthesis, Themes and Future Directions</p>